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Abstract 
 
Objective ​​: Deep learning algorithms have been used to detect diabetic retinopathy (DR) with 
specialist-level accuracy. This study aims to validate one such algorithm on a large-scale clinical 
population, and compare the algorithm performance with that of human graders.  
 
Research Design and Methods: ​​25,326 gradable ​retinal images of patients with diabetes from 
the community-based, nation-wide screening program of DR in Thailand were analyzed for DR 
severity and referable diabetic macular edema (DME). Grades adjudicated by a panel of 
international retinal specialists served as the reference standard.  
 
Results ​​: Relative to human graders, for detecting referable DR (moderate NPDR or worse), the 
deep learning algorithm had significantly higher sensitivity (0.97 vs. 0.74, ​p​<0.001), and a 
slightly lower specificity (0.96 vs. 0.98, ​p​<0.001). Higher sensitivity of the algorithm was also 
observed for each of the categories of severe or worse DR, PDR, and DME ( ​p​<0.001 for all 
comparisons). The quadratic-weighted kappa for determination of DR severity levels by the 
algorithm and human graders was 0.85 and 0.78 respectively (​p​<0.001 for the difference). 
 
Conclusions​​: Across different severity levels of DR for determining referable disease, deep 
learning significantly reduced the false negative rate (by 23%) at the cost of slightly higher false 
positive rates (2%). Deep learning algorithms may serve as a valuable tool for DR screening. 
 
 
  
Introduction 
Deep learning (DL) is a field of artificial intelligence which has been applied to develop 
algorithms for the detection of diabetic retinopathy (DR) with high (>90%) sensitivity and 
specificity for referable disease (moderate non-proliferative diabetic retinopathy (NPDR) or 
worse) ​(1–3) ​. In addition to high screening accuracy, DL also has advantages in terms of 
resource consumption, consistency, and scalability, and has the potential to be deployed as an 
alternative to human graders for classifying or triaging retinal photographs in DR screening 
programs. 
In Thailand, there are 1,500 ophthalmologists, including 200 retinal specialists, who 
provide ophthalmic care to approximately 4.5 million patients with diabetes. Half of the 
ophthalmologists and retinal specialists practice in Bangkok, the capital of the country, while a 
majority of patients with diabetes live in areas 100 kilometers or more from provincial hospitals, 
where ophthalmologists typically practice. The latest Thailand National Survey of Blindness 
conducted in 2006-2007 ​(4) ​ showed that 34% of patients with diabetes had low vision or 
blindness in either eye. DR was and continues to be the most common retinal disease that causes 
bilateral low vision ​(4,5) ​. 
A national screening program for DR was set up by the Ministry of Public Health of 
Thailand in 2013. The screening was conducted in each of the 13 health regions with an initial 
target of screening at least 60% of diabetic patients in each region. Unfortunately, Ministry data 
indicates that less than 50% of the diabetic patients were screened every year since the inception 
of the program. Because this was in part due to the lack of trained graders, deploying DL in the 
 
 screening program for DR in Thailand has the potential to solve some of these problems ​(6) ​. 
Similar issues have been observed in the United Kingdom ​(7) ​. 
Several DL algorithms for DR have shown promise in populations with multiethnic 
diabetic patients ​(1–3) ​. However, before the deployment of DL for screening DR,  additional 
large-scale validation on screening populations that are distinct from the original developmental 
datasets will be critical. In addition, the use of rigorous reference standards that are adjudicated 
by retinal specialists is important for robust evaluation of the algorithm and human graders ​(2) ​. 
Lastly, the diagnostic accuracy of DL algorithms should be compared with human graders who 
routinely grade retinal images in a screening population.  
This study was conducted to assess the screening performance of the DL algorithm 
compared to real-world graders for classifying multiple clinically relevant severity levels of DR 
in the national screening program for DR in Thailand.  
 
Research Design & Methods 
This study was approved by the Ethical Review Committee for Research in Human 
Subjects of the Ministry of Public Health of Thailand and the Ethical Committees of hospitals or 
health centers from which retinal images of patients with diabetes were used. Patients gave 
informed consents allowing their retinal images to be used for research. This study was 
registered in the Thai Clinical Trials Registry, Reg​istration Number TCTR20180716003. 
 
Data acquisition 
 
 Diabetic patients were randomly identified from a national registry of diabetic patients, 
representing hospitals or health centers in each of the 13 health regions in Thailand. Patients 
were included if they had fundus images of either eye captured using retinal cameras in both the 
years 2015 and 2017, as part of a 2-year longitudinal study on DR. Retinal images of the patients 
were single-field, 45-degree field of view, and contained the optic disc and macula, centered on 
the macula. A variety of cameras were used for image acquisition including ones manufactured 
by 3nethra, Canon, Kowa, Nidek, Topcon, and Zeiss (Supplemental Table S6) ​.​ Images were 
retrieved from the digital archives from retinal cameras utilized in the Thailand DR national 
screening program. Images were excluded from analysis if they were from patients who had 
other retinal diseases that precluded classification of severity of DR or DME, such as age-related 
macular degeneration (AMD) and other retinal vascular diseases. 
 
Definition of DR severity levels and DME 
Severity levels of DR and DME were defined according to the International Clinical 
Classification of DR (ICDR) disease severity scale ​(8) ​. In short, DR was classified into no DR, 
mild non-proliferative DR (NPDR), moderate NPDR, severe NPDR, and proliferative DR 
(PDR). DME was identified as referable DME when hard exudates were found within the 
distance of 1 disc-diameter from the center of the fovea ​(9,10) ​. 
 
Sample size estimation 
According to previous community-based studies of DR in Thailand ​(11)​, the prevalence 
of sight-threatening DR (PDR, severe NPDR, or DME) was approximately 6% of patients with 
 
 diabetes. With a margin of error of 10%, type 1 error at 0.5 and type 2 error at 0.2, the sample 
size was estimated at no less than 6,112 patients with diabetes. A rate of ungradable images at 
20% was estimated, therefore, at least 7,450 patients with diabetes were required. The 
distribution of diabetic patients included from each region was in proportion with the distribution 
of diabetic patients form  each region. The numbers of patients from each of the 13 regions are 
listed in Table 1. 
 
Deep learning algorithm  
The development of the deep learning algorithm for predicting DR and DME is described 
in detail in Krause ​et al​. ​(2) ​ Briefly, a convolutional neural network was trained with an 
“Inception-v4” ​(12)​ architecture that predicted a 5-point DR grade, referable DME, gradability of 
both DR and DME, and an overall image quality score. The input to the neural network was a 
fundus image with a resolution of 779 x 779 pixels. Through the use of many stages of 
computation, parameterized by millions of numbers, the network outputs a real-valued number 
between 0.0 and 1.0 for each prediction, indicating its confidence. During training, the model 
was given different images from the training set with a known severity rating for DR, and the 
model predicted its confidence in each severity level of DR, slowly adjusting its parameters over 
the course of the training process to increase its accuracy. The model was evaluated on a tuning 
dataset throughout the training process, which was used to determine model hyperparameters. An 
“ensemble” of ten individual models was then created to combine their predictions for the final 
output. To turn the model’s confidence-based outputs into discrete predictions, a threshold on the 
 
 confidence was used for each binary output (DME, DR Gradability, and DME Gradability), and 
a cascade of thresholds ​(2) ​ was used to output a single DR Severity level. 
 
Grading by regional graders 
The DL algorithm was compared to 13 human regional graders who actually grade retinal 
images for the screening program in each of the 13 health regions.  In this study, each grader 
only graded images that have been screened in his or her own region. Some of the graders were 
general ophthalmologists and others were trained ophthalmic nurses or technicians. Each grader 
received standard grading protocols for DR and DME, including instructions for the web-based 
grading tool before the commencement of the study, and each was required to use the same 
web-based tool for online grading of the retinal images. A tutorial session was conducted for all 
the graders before the commencement of grading. 
 
Reference standard  
There were 2 groups of retinal specialists who graded retinal images for the reference 
standard. One group was assigned to grade for DR severity level and another for referable DME. 
For gradability, a subset of ~1000 images each for DR and DME where the regional 
grader disagreed with the DL algorithm on image gradability underwent adjudication. For the 
remainder of the analysis for both DR and DME, images graded as ungradable by either the 
algorithm or regional grader were excluded. Additionally, for images which were not adjudicated 
but the DL algorithm and regional graders were in agreement about the severity of DR, the 
 
 agreed-upon grade was used as the reference standard. A similar rule was applied for analysis of 
DME.  
For grading DR severity levels the ICDR scale was used. In order to reduce adjudication 
time for quality of grading, adjudicators were assigned to grade a subset of the images. This 
subset included all images for which the regional grader and the DL algorithm were in 
disagreement and at least one graded as moderate NPDR or worse; a random sample of 75 
images for which the algorithm and regional grader were in agreement and graded as moderate 
NDPR or worse; and a random sample of 1,175 images for which the algorithm and regional 
grader both graded as less than moderate NPDR. This random sample represented 5% of all 
images with agreement between the two modalities. The ratio of images with moderate NPDR or 
worse to those with less than moderate NPDR in this random sample was proportional to the 
entire population. For the purposes of this study, no DR and mild DR were considered a single 
category, and only images that both the algorithm and regional grader deemed gradable for DR 
were adjudicated. For grading referable DME, retinal specialists were assigned to grade all 
images for which the regional graders and DL were in disagreement about the binary presence or 
absence of DME, and 5% of the rest of the images were randomly assigned from the subset of 
those images also determined to be gradable for DME by both the regional grader and the 
algorithm. Most of the disagreement occurred in cases that were graded as moderate or worse 
DR or referable DME. Further review of the discrepancies revealed that most of the cases were 
fairly ambiguous and adjudicators tended to err on the side of increased sensitivity for a 
screening setting. Overall, for moderate or worse DR, the regional grader and algorithm grade 
agreed with adjudication 96.3% of the time. For DME, the agreement rate was 97.1%.  
 
 The retinal specialists that served as the reference standard in this study were from 
Thailand, India, and the United States. There were two retinal specialists per group. Each group 
graded the images independently, and the same instructions for web-based grading that the 
regional graders used were issued to them before grading. They were also required to use the 
same web-based grading tool as the regional graders. In addition, the group that graded DR 
severity level had a teleconference and graded a small set of images together to ensure 
congruence. 
The adjudication process was as follows: First, both retinal specialists in a group 
independently graded each image. Then, until consensus was reached, the retinal specialists took 
turns revising their grades, each time with access to their previous grade and the other retinal 
specialist’s grade, as well as any additional comments about the case either retinal specialist left. 
If there was still disagreement after each grader had graded the image three times in this way, 
then the image’s reference standard was determined independently by a separate, senior retinal 
specialist. For grading DR severity levels, differences between no DR and mild NPDR were not 
adjudicated in order to focus adjudication time on referable disease. 
  
Statistical Analysis 
Primary metrics assessed were sensitivity, specificity, and area under the receiver 
operating characteristic curve (AUC). Confidence intervals for sensitivities and specificities were 
calculated using a Clopper-Pearson interval, and confidence intervals for the quadratic-weighted 
Cohen’s kappa was calculated using a bootstrap, both calculated at the 95% level. All P-values 
were calculated using two-sided permutation tests. 
 
  
Results 
The characteristics of the images and patients included in this study are described in 
Table 1. ​ This cohort consisted from 7,517 patients, of which 67.5% were women. The average 
age was 61.13 (SD = 10.96).  
Out of 29,943 images, 4,595 were deemed not gradable for DR by either the regional 
grader, the DL algorithm, or both (Supplemental Table S1). A sample of images where the 
regional grader disagreed with the DL algorithm on image gradability underwent adjudication 
and the results of the adjudication are presented in the Supplemental Tables S2 and S3. 
Adjudicators were approximately 2.5 times more likely to agree with the algorithm than regional 
graders about the gradability of images for DR. For this difficult image subset, adjudicators 
agreed with the regional grader 28.5% of the time vs 71.5% of the time with the algorithm. For 
DME gradability, they were just as likely to agree with the algorithm as the regional graders.  
A comparison of the performance of regional graders in Thailand and the algorithm 
compared to the reference standard for all gradable images is summarized in Supplementa​l Table 
S4. ​ Out of all of the gradable images, the composite sensitivity (i.e. generated by pooling all of 
the patients and then computing the metric) of the graders for detecting moderate or worse DR 
was 0.740 (ranging from 0.413-0.954 across regional graders) and the specificity was 0.982 
(range: 0.943-1.000). The DL algorithm had a sensitivity of 0.970 (range: 0.887-0.993), 
specificity of 0.957 (range: 0.903-0.987) and AUC of 0.988 (range: 0.978-0.996) (Figure 1). 
These differences in sensitivity (23%) and specificity (-2.5%) between the algorithm and 
regional graders were statistically significant (​p ​<0.001). The algorithm also showed performance 
 
 better than or equal to that of composite grading of regional graders for severe or worse DR and 
PDR, with AUC values of 0.991 (range: 0.978-0.997) and 0.994 (range: 0.974-1.00), respectively 
(Figure 1). Using moderate or worse DR as the threshold for referral for regional graders would 
result in a sensitivity of 0.917 (95% CI 0.870-0.951) for severe or worse DR. For the algorithm, 
this would correspond to a sensitivity of 0.990 (95% CI: 0.965-0.999). For PDR, the graders 
would have a sensitivity of 0.859 (95% CI: 0.821-0.892) and the algorithm would have a 
sensitivity of 0.955 (95% CI: 0.929-0.973).  
Results for DME were similar. The sensitivity for regional graders for detecting referable 
DME was 0.613 (range: 0.421-0.805 across regions), and the specificity was 0.992 (range: 
0.973-0.999). For the DL algorithm, sensitivity was measured at 0.940 (range: 0.847-1.000), 
specificity was measured at 0.982 (range: 0.947-0.992), and AUC of 0.993 (range: 0.981-0.998; 
95% CI 0.991-0.994).  
Because more rapid referral is warranted for cases with severe or worse DR and/or DME, 
the performance of the algorithm for these cases was also examined. At this threshold, regional 
graders had a sensitivity of 0.603 (range: 0.308-0.782), specificity of 0.997 (range: 0.993-0.999), 
while the algorithm had a sensitivity of 0.927 (range: 0.810-1.000) and specificity of 0.976 
(range: 0.915-0.993). Using PDR and/or DME as the threshold yields similar performance 
metrics as severe or worse DR and/or DME because the number of DME cases outnumbers that 
of PDR cases (Figure S1). Additional results for using individual DR severity levels as the 
threshold are summarized in Supplemental Figure S1. 
The performance of the graders cannot be directly compared to each other because they 
each graded a different set of images that correspond to their region. However, the algorithm’s 
 
 performance for images from each region could be compared directly to the regional grader from 
that region (Figure 2). In nearly all regions, the algorithm’s sensitivity was significantly higher 
than that of the respective regional grader for moderate or worse DR and for DME. In region 5, 
the algorithm’s sensitivity was lower than that of the regional grader for moderate or worse DR, 
but the difference was not statistically significant ( ​p​=0.83). 
The overall agreement between the regional graders and algorithm in comparison to the 
reference standard for DR and DME is shown in a confusion matrix presented in Table 2. 
Furthermore, to compare the agreement for the entire range of DR severities (No/Mild, 
Moderate, Severe, and Proliferative) and for each region, quadratic-weighted Cohen’s kappa was 
used (Supplemental Table S5). Regional graders were measured at 0.728 (range: 0.504-0.853 
across regions) and 0.776 (range: 0.663-0.878), ​p ​<0.001 for the difference.  
While the output of the algorithm is ultimately distilled in a categorical call (e.g. severe 
NPDR vs PDR), the algorithm originally returns a value between 0 and 1 for each level of DR 
and DME, indicating a confidence for each severity level. Analysis of the model’s performance 
based on the maximum score of both the DR and DME predictions showed that the algorithm 
was more sensitive than regional graders at all ranges of confidence score. However, when the 
algorithm was uncertain (maximum score < 0.7), the specificity of the algorithm was much lower 
than that of the regional grader at this particular operating point (Figure S2). 
 
Conclusions 
This study represents one of the largest clinical validations of a deep learning algorithm 
in a population that is distinct from which the algorithm was trained. In addition, this external 
 
 validation was conducted in direct comparison with the actual graders in the screening program 
of the same population. ​This is pivotal since many countries in the world adopted trained graders 
for their screening programs for DR. These include the UK ​(13) ​, Malaysia ​(14) ​, South Africa 
(15) ​, among others. Furthermore, according to the statement by American Academy of 
Ophthalmology (AAO) ​(15,16)​, ​there is a strong (level 1) evidence that single-field retinal 
photography with interpretation by trained graders can serve as a screening tool to identify 
patients with DR for referral for ophthalmic evaluation and management. 
Most algorithms in previous studies of DL for DR screening have simplified the various 
levels of DR into binary predictions, either referable and non-referable or with and without 
sight-threatening DR. However, in real-world situations patient management can be different at 
each level of DR. For example, patients with PDR may require higher urgency for referral for 
panretinal photocoagulation or intravitreal injections compared to another severity level, such as 
severe NPDR without diabetic macular edema (DME). On the other hand, patients with moderate 
NPDR without DME, although labelled as referable, may not require treatment but still require 
periodic close monitoring by ophthalmologists or retinal specialists. Identifying the referable 
group of patients requiring treatment accurately may save community resources. Validation of 
the performance of DL for classifying severity levels of DR would therefore be essential for 
real-world screening of DR.  
Prior to this study, one of the largest head-to-head comparisons between deep learning 
and human graders was performed by Ting ​et al. ​ The study included 10 secondary validation sets 
(e.g. validation sets that were drawn from a population that is distinct from the one in which the 
model was trained), the largest consisting of over 15,000 images. The algorithm validated in this 
 
 study build upon this body of work by not only showed excellent generalization on a national 
level across different cameras (Supplemental Table S6) and graders, but also high accuracy when 
measured on both binary and multi-class tasks. Grading on a more granular 5-point grade is 
advantageous, especially on a global scale, where follow up and management guidelines amongst 
the many different guidelining bodies may vary at each of the 5 levels and in the presence of 
possible macular edema ​(17)​. For example, while the follow up recommended by the AAO 
(15,16,18) ​ can be up to 12 months for moderate NPDR with no macular edema, that 
recommendation changes to 3-6 months if there is macular edema and 1 month when there is 
clinically significant macular edema ​(16) ​.  
The threshold level for referral in a screening program for DR may be dependent on the 
resources of the program. In a lower resource setting where ophthalmologists only see severe 
cases, the referral threshold may be higher. In a higher resource setting where ophthalmologists 
prefer to see mild cases, the referral threshold may be lower. There has been some work in the 
literature to address the importance of this 5-severity levels grading of DR and an adjudicated 
reference standard ​(8)​. However, this work was not validated on a dataset from a different 
population until this present study. External validation of a deep learning system for accuracy of 
a 5-point grade should not only give an advantage for selecting an appropriate threshold with 
acceptable accuracy for a screening system but also act as a feedback loop to tune the accuracy 
of the deep learning system itself.  
This study could be further improved upon. First, adjudication was performed only for 
moderate or worse cases. ​For patients with no retinopathy, screening every 2 years may be 
appropriate while those with mild NPDR should be screened once a year ​(19)​. Therefore, future 
 
 studies should include adjudication for cases where there is disagreement between no and mild 
DR. Furthermore, the algorithm’s performance could be improved upon for difficult cases. For 
example, ​the sensitivity for correctly detecting PDR of our deep learning algorithm was only 
0.719 in this study. Even though the algorithm did not miss cases with active neovascularization 
but rather primarily missed cases with inactive fibrous tissue without neovascularization at the 
optic disc, additional training could help improve the algorithm for these cases in the future. ​In 
addition, in a real-life screening setting, grading may be performed with a combination of 
automated and manual grading. A preliminary analysis was performed to look at the relationship 
between algorithm confidence and performance of both algorithm and manual grading. Future 
studies could further explore how to combine the algorithm and manual grading to achieve better 
performance than either alone, while minimizing manual grading workload. In addition, the 
reference standard for DME in this study was based on monoscopic fundus photos. For DME, 
OCT is now considered the clinical standard, and incorporating this in the reference standard 
would be ideal ​(20)​. Lastly, DR screening programs generally also refer patients at high 
suspicion for other non-DR eye diseases such as AMD or glaucoma. The ability to detect other 
eye diseases would further increase the utility of these algorithms. 
This study represents an early milestone in the implementation of a DL algorithm in a 
large scale DR screening program. The demonstration of the algorithm’s performance and 
generalizability compared to actual graders in a screening program lays the groundwork for other 
prospective studies -- to further validate the algorithm’s performance in real screening workflows 
and to study its impact on DR screening as a whole. It is possible that, due to human nature, 
graders are generally more reluctant to make a commitment for diagnosis, compared with the 
 
 algorithm; this may have made their gradings more specific but less sensitive. While it is critical 
that a DL algorithm is accurate, it is equally important to study how the algorithm may affect 
clinical workflow and outcomes of patients, such as clinician and patient satisfaction, patient 
adherence to follow-up recommendations, and ultimately impact on disease prevention, 
progression and outcomes. 
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 Tables & Figures  
 
Grader Type 
All 
regions 1 2 3 4 5 6 7 8 9 10 11 12 13 
Grader Type  MD MD MD MD MD MD Nurse MD Nurse Nurse Nurse Nurse Tech 
Total Patients 7,517 100 620 569 440 513 620 680 1,005 750 370 500 250 1,000 
Total Images 29,985 764 2,467 2,256 1,760 2,051 2,424 2,720 4,020 2,989 1,582 1,986 968 3,998 
% No/Mild DR 87.83 68.30 92.32 94.02 92.95 87.85 88.81 82.85 82.10 89.62 75.24 92.45 86.67 93.81 
% Moderate 
NPDR 9.80 23.84 5.65 5.35 5.17 7.40 8.77 12.53 16.21 8.14 20.06 6.15 10.75 5.39 
% Severe 
NPDR 0.81 3.23 0.60 0.19 0.77 0.56 0.75 1.38 0.57 1.30 1.16 0.27 1.34 0.40 
% PDR 1.57 4.63 1.43 0.43 1.12 4.18 1.67 3.24 1.11 0.94 3.55 1.14 1.23 0.40 
% Referable 
DME 6.23 17.41 3.08 3.50 3.30 4.00 7.47 8.68 8.81 6.62 15.42 3.83 6.20 2.30 
% Female 69 66 61 67 68 65 69 69 77 71 64 75 63 68 
% Male 31 34 39 33 32 35 31 31 23 29 36 25 37 32 
Age 
59 (52, 
66) 
58 (53, 
64) 
57 
(50, 
63) 
59 
(52, 
66) 
63 
(57, 
70) 
62 
(54, 
70) 
58 
(51, 
65) 
62 
(54, 
68) 
59 (53, 
66) 
56 (49, 
64) 
56 
(49, 
64) 
63 (56, 
71) 
56 (50, 
61) 
59 (51, 
67) 
HbA1c (%) 
7.3 (6.5, 
8.6) 
7.6 
(6.9, 
8.5) 
7.0 
(6.4, 
8.2) 
7.3 
(6.4, 
8.5) 
7.2 
(6.5, 
8.4) 
7.2 
(6.3, 
8.5) 
7.2 
(6.5, 
8.1) 
7.7 
(6.8, 
9.3) 
7.6 
(6.5, 
9.1) 
7.2 
(6.3, 
8.5) 
8.4 
(7.3, 
9.8) 
7.2 
(6.5, 
8.2) 
8.1 
(7.1, 
9.6) 
7.0 (6.3, 
8.0) 
FBS (mg/dL) 
139 (118, 
169) 
130 
(110, 
172) 
136 
(118, 
168) 
138 
(115, 
166) 
133 
(114, 
156) 
150 
(126, 
181) 
140 
(122, 
175) 
140 
(118, 
199) 
144 
(121, 
172) 
133 
(107, 
170) 
149 
(122, 
188) 
131 
(115, 
154) 
149 
(130, 
186) 
136 
(118, 
163) 
LDL (mg/dL) 
105 (83, 
130) 
117 
(107, 
147) 
113 
(90, 
135) 
102 
(79, 
124) 
101 
(81, 
128) 
94 
(75, 
120) 
103 
(80, 
129) 
102 
(93, 
122) 
109 
(86, 
132) 
107 
(86, 
131) 
104 
(85, 
124) 
96 (73, 
119) 
118 
(96, 
142) 
108 (88, 
132) 
 
Table 1.​​ Summary of patient characteristics, including breakdowns by region. For blood sample 
measures and visual acuity, values reflect the distribution across patients at first visit.  MD = 
Ophthalmologist;  n/a: Data not collected in these regions. Numeric values indicate the median across a 
distribution; values in parentheses indicate the 25th and 75th percentiles. 
  
 
  
 
 Regional Grader Label 
No/Mild 
NPDR 
Moderate 
NPDR  
Severe 
NPDR 
Proliferative 
DR 
 
 
Reference 
Standard 
No/Mild 21,843 355 12 33 
Moderate 
NPDR 
729 1,724 13 15 
Severe NPDR 17 79 100 8 
Proliferative 
DR 
56 87 14 241 
 
Quadratic-Weighted Kappa: 0.776 [0.757-0.792] 
 
 
 Algorithm Label 
No/Mild 
NPDR 
Moderate 
NPDR 
Severe 
NPDR 
Proliferative 
DR 
 
 
Reference 
Standard 
No/Mild NPDR 21,288 902 38 15 
Moderate 
NPDR 
72 1,866 525 18 
Severe NPDR 2 6 192 4 
Proliferative 
DR 
18 18 76 286 
 
Quadratic-Weighted Kappa: 0.846 [0.835-0.856] 
 
 Regional Grader Label 
No DME DME 
Reference 
Standard 
No DME 22,182 168 
DME 723 1,146 
  
 
  
 Algorithm Label 
No DME DME 
Reference 
Standard 
No DME 21,951 399 
DME 112 1757 
 
Table 2. ​​Agreement on the image level between the reference standard and regional graders or the 
algorithm for DR severity grading and DME. Adjudication was performed only for images where either the 
regional grader or the algorithm identified as moderate and above. Thus, for DR, non-referable cases 
(No/Mild) are combined into a non-referable bucket.  
 
 
 
 
 
Figure 1.​​ ROC curve of model performance (blue line) compared to grading by regional graders (red dot) 
for varying severities of DR and DME. The performance represented by the red dot is a combination of all 
of the grades from the regional graders on all gradable images, since regional graders only graded 
images from their own region. 
 
  
A. Moderate or worse DR 
 
 
B. DME 
 
  
 
  
C. Severe or worse DR and/or DME 
 
 
Figure 2.​​ Comparison of the performance of the algorithm with regional graders for varying severities and 
combination of DR and DME for all gradable images. The rest of the combinations are in Supplemental 
Figure 1. 
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 Algorithm 
DR Gradable DR Ungradable 
 
Regional 
Grader 
DR Gradable 25,348 1,765 
DR Ungradable 1,239 1,591 
 
 Algorithm 
DME Gradable DME Ungradable 
 
Regional 
Grader 
DME Gradable 24,332 2,467 
DME Ungradable 1,036 2,108 
 
Table S1. ​​Agreement between regional graders and the algorithm for determining image gradability for DR and DME. 
 
  
  Regional Grader 
DR Gradable DR Ungradable 
 
Adjudication 
DR Gradable 56 155 
DR Ungradable 547 224 
 
 Algorithm 
DR Gradable DR Ungradable 
 
Adjudication 
DR Gradable 155 56 
DR Ungradable 224 547 
 
Table S2​​. Agreement between the adjudicated reference standard and the regional grader or the algorithm for images 
where the regional grader and the algorithm disagreed on DR gradability.  
  
  Regional Grader 
DME Gradable DME Ungradable 
 
Adjudication 
DME Gradable 493 277 
DME Ungradable 196 28 
 
 Algorithm 
DME Gradable DME Ungradable 
 
Adjudication 
DME Gradable 277 493 
DME Ungradable 28 196 
 
Table S3. ​​Agreement between the adjudicated reference standard and the regional grader or the algorithm for images 
where the regional grader and the algorithm disagreed on DME gradability. 
  
 
 Moderate or Worse DR Severe or Worse DR Proliferative DR DME 
  Sensitivity Specificity AUC  Sensitivity Specificity AUC  Sensitivity Specificity AUC  Sensitivity Specificity AUC 
Regi
on 
Cou
nt 
Regional 
Grader Algorithm 
Regional 
Grader Algorithm 
Algorit
hm 
Cou
nt 
Regional 
Grader Algorithm 
Regional 
Grader Algorithm 
Algorit
hm 
Cou
nt 
Regional 
Grader Algorithm 
Regional 
Grader Algorithm 
Algor
ithm 
Cou
nt 
Regional 
Grader Algorithm 
Regional 
Grader Algorithm 
Algori
thm 
All 
308
3 
0.740 
[0.724-0.7
55] 
0.970 
[0.964-0.9
76] 
0.982 
[0.980-0.9
84] 
0.957 
[0.954-0.9
60] 0.988 602 
0.603 
[0.563-0.6
42] 
0.927 
[0.903-0.9
46] 
0.997 
[0.996-0.9
98] 
0.976 
[0.974-0.9
78] 0.991 398 
0.606 
[0.556-0.6
54] 
0.719 
[0.672-0.7
62] 
0.998 
[0.997-0.9
98] 
0.999 
[0.998-0.9
99] 
0.99
4 
186
9 
0.613 
[0.591-0.6
35] 
0.940 
[0.928-0.9
50] 
0.992 
[0.991-0.9
94] 
0.982 
[0.980-0.9
84] 0.993 
1 226 
0.836 
[0.781-0.8
82] 
0.987 
[0.962-0.9
97] 
0.973 
[0.955-0.9
86] 
0.903 
[0.874-0.9
28] 0.982 56 
0.607 
[0.468-0.7
35] 
0.982 
[0.904-1.0
00] 
0.997 
[0.989-1.0
00] 
0.915 
[0.891-0.9
35] 0.988 33 
0.788 
[0.611-0.9
10] 
0.848 
[0.681-0.9
49] 
0.999 
[0.992-1.0
00] 
0.994 
[0.985-0.9
98] 
0.99
3 133 
0.805 
[0.727-0.8
68] 
0.955 
[0.904-0.9
83] 
0.993 
[0.982-0.9
98] 
0.947 
[0.925-0.9
64] 0.981 
2 140 
0.607 
[0.521-0.6
89] 
0.993 
[0.961-1.0
00] 
1.000 
[0.998-1.0
00] 
0.955 
[0.944-0.9
65] 0.996 37 
0.649 
[0.475-0.7
98] 
0.946 
[0.818-0.9
93] 
0.999 
[0.997-1.0
00] 
0.983 
[0.976-0.9
89] 0.997 26 
0.692 
[0.482-0.8
57] 
0.885 
[0.698-0.9
76] 
1.000 
[0.998-1.0
00] 
0.998 
[0.995-1.0
00] 
0.99
8 76 
0.421 
[0.309-0.5
40] 
0.934 
[0.853-0.9
78] 
0.999 
[0.996-1.0
00] 
0.989 
[0.982-0.9
93] 0.995 
3 125 
0.560 
[0.468-0.6
49] 
0.992 
[0.956-1.0
00] 
0.996 
[0.993-0.9
99] 
0.950 
[0.940-0.9
59] 0.991 13 
0.308 
[0.091-0.6
14] 
0.846 
[0.546-0.9
81] 
0.999 
[0.997-1.0
00] 
0.991 
[0.986-0.9
95] 0.995 9 
0.444 
[0.137-0.7
88] 
0.444 
[0.137-0.7
88] 
0.999 
[0.997-1.0
00] 
1.000 
[0.998-1.0
00] 
0.99
1 79 
0.494 
[0.379-0.6
09] 
0.949 
[0.875-0.9
86] 
0.998 
[0.996-1.0
00] 
0.992 
[0.988-0.9
96] 0.998 
4 101 
0.663 
[0.562-0.7
54] 
0.970 
[0.916-0.9
94] 
0.980 
[0.972-0.9
87] 
0.964 
[0.952-0.9
73] 0.980 27 
0.630 
[0.424-0.8
06] 
0.889 
[0.708-0.9
76] 
0.994 
[0.988-0.9
97] 
0.985 
[0.977-0.9
91] 0.978 16 
0.438 
[0.198-0.7
01] 
0.750 
[0.476-0.9
27] 
0.995 
[0.990-0.9
98] 
0.999 
[0.995-1.0
00] 
0.97
4 58 
0.638 
[0.501-0.7
60] 
0.983 
[0.908-1.0
00] 
0.996 
[0.990-0.9
99] 
0.974 
[0.963-0.9
83] 0.993 
5 151 
0.901 
[0.841-0.9
43] 
0.887 
[0.826-0.9
33] 
0.952 
[0.938-0.9
64] 
0.984 
[0.974-0.9
90] 0.988 59 
0.695 
[0.561-0.8
08] 
0.831 
[0.710-0.9
16] 
0.997 
[0.991-0.9
99] 
0.980 
[0.970-0.9
87] 0.988 52 
0.731 
[0.590-0.8
44] 
0.673 
[0.529-0.7
97] 
0.998 
[0.994-1.0
00] 
0.997 
[0.993-0.9
99] 
0.99
2 82 
0.524 
[0.411-0.6
36] 
0.976 
[0.915-0.9
97] 
0.998 
[0.993-1.0
00] 
0.970 
[0.959-0.9
80] 0.995 
6 254 
0.413 
[0.352-0.4
77] 
0.980 
[0.955-0.9
94] 
0.991 
[0.986-0.9
95] 
0.937 
[0.925-0.9
47] 0.990 55 
0.782 
[0.650-0.8
82] 
0.909 
[0.800-0.9
70] 
0.993 
[0.988-0.9
96] 
0.975 
[0.967-0.9
81] 0.990 38 
0.737 
[0.569-0.8
66] 
0.658 
[0.486-0.8
04] 
0.996 
[0.992-0.9
98] 
0.997 
[0.994-0.9
99] 
0.99
4 181 
0.575 
[0.499-0.6
48] 
0.978 
[0.944-0.9
94] 
0.973 
[0.965-0.9
80] 
0.975 
[0.967-0.9
81] 0.995 
7 349 
0.636 
[0.583-0.6
87] 
0.971 
[0.948-0.9
86] 
0.991 
[0.985-0.9
95] 
0.942 
[0.930-0.9
53] 0.987 94 
0.340 
[0.246-0.4
45] 
0.926 
[0.853-0.9
70] 
0.999 
[0.996-1.0
00] 
0.955 
[0.944-0.9
63] 0.983 66 
0.258 
[0.158-0.3
80] 
0.606 
[0.478-0.7
24] 
1.000 
[0.998-1.0
00] 
0.998 
[0.995-0.9
99] 
0.98
6 236 
0.564 
[0.498-0.6
28] 
1.000 
[0.984-1.0
00] 
0.998 
[0.994-1.0
00] 
0.978 
[0.970-0.9
85] 0.997 
8 659 
0.954 
[0.936-0.9
69] 
0.983 
[0.970-0.9
92] 
0.961 
[0.953-0.9
68] 
0.963 
[0.956-0.9
69] 0.990 62 
0.645 
[0.513-0.7
63] 
0.968 
[0.888-0.9
96] 
0.999 
[0.998-1.0
00] 
0.971 
[0.965-0.9
76] 0.993 41 
0.780 
[0.624-0.8
94] 
0.732 
[0.571-0.8
58] 
0.999 
[0.998-1.0
00] 
0.999 
[0.997-1.0
00] 
0.99
7 354 
0.785 
[0.739-0.8
27] 
0.847 
[0.806-0.8
83] 
0.993 
[0.989-0.9
95] 
0.984 
[0.979-0.9
88] 0.984 
9 288 
0.444 
[0.386-0.5
04] 
0.990 
[0.970-0.9
98] 
0.995 
[0.991-0.9
97] 
0.945 
[0.935-0.9
53] 0.991 62 
0.694 
[0.563-0.8
04] 
0.952 
[0.865-0.9
90] 
0.993 
[0.989-0.9
96] 
0.981 
[0.975-0.9
86] 0.995 26 
0.577 
[0.369-0.7
66] 
0.692 
[0.482-0.8
57] 
0.992 
[0.988-0.9
95] 
0.999 
[0.996-1.0
00] 
0.99
4 198 
0.444 
[0.374-0.5
17] 
0.894 
[0.842-0.9
33] 
0.989 
[0.985-0.9
93] 
0.989 
[0.985-0.9
93] 0.992 
10 342 
0.898 
[0.861-0.9
28] 
0.942 
[0.911-0.9
64] 
0.943 
[0.927-0.9
56] 
0.959 
[0.945-0.9
70] 0.986 65 
0.569 
[0.440-0.6
92] 
0.954 
[0.871-0.9
90] 
0.998 
[0.993-1.0
00] 
0.945 
[0.931-0.9
56] 0.987 49 
0.571 
[0.422-0.7
12] 
0.735 
[0.589-0.8
51] 
0.998 
[0.993-1.0
00] 
0.998 
[0.995-1.0
00] 
0.99
7 244 
0.586 
[0.521-0.6
49] 
0.980 
[0.953-0.9
93] 
0.996 
[0.990-0.9
99] 
0.962 
[0.949-0.9
73] 0.993 
11 113 
0.735 
[0.643-0.8
13] 
0.965 
[0.912-0.9
90] 
0.965 
[0.954-0.9
74] 
0.987 
[0.980-0.9
92] 0.996 21 
0.714 
[0.478-0.8
87] 
0.810 
[0.581-0.9
46] 
0.994 
[0.988-0.9
97] 
0.986 
[0.979-0.9
92] 0.992 17 
0.824 
[0.566-0.9
62] 
0.706 
[0.440-0.8
97] 
0.997 
[0.992-0.9
99] 
0.999 
[0.996-1.0
00] 
0.99
4 76 
0.566 
[0.447-0.6
79] 
0.961 
[0.889-0.9
92] 
0.983 
[0.975-0.9
89] 
0.992 
[0.986-0.9
96] 0.998 
12 119 
0.924 
[0.861-0.9
65] 
0.992 
[0.954-1.0
00] 
0.977 
[0.963-0.9
86] 
0.948 
[0.930-0.9
63] 0.996 23 
0.522 
[0.306-0.7
32] 
1.000 
[0.852-1.0
00] 
0.998 
[0.992-1.0
00] 
0.967 
[0.952-0.9
78] 0.996 11 
0.273 
[0.060-0.6
10] 
0.909 
[0.587-0.9
98] 
0.999 
[0.994-1.0
00] 
0.999 
[0.994-1.0
00] 
0.99
5 60 
0.683 
[0.550-0.7
97] 
0.967 
[0.885-0.9
96] 
0.988 
[0.978-0.9
95] 
0.983 
[0.971-0.9
91] 0.996 
13 216 
0.694 
[0.628-0.7
55] 
0.940 
[0.899-0.9
68] 
0.996 
[0.993-0.9
98] 
0.971 
[0.965-0.9
77] 0.978 28 
0.750 
[0.551-0.8
93] 
0.929 
[0.765-0.9
91] 
0.999 
[0.998-1.0
00] 
0.993 
[0.989-0.9
95] 0.991 14 
0.786 
[0.492-0.9
53] 
0.929 
[0.661-0.9
98] 
0.999 
[0.998-1.0
00] 
1.000 
[0.998-1.0
00] 
1.00
0 92 
0.630 
[0.523-0.7
29] 
0.946 
[0.878-0.9
82] 
0.997 
[0.995-0.9
99] 
0.987 
[0.982-0.9
90] 0.994 
 
Table S4.​​ Performance of the grader compared to the algorithm by region for DR and DME at different severity thresholds for all gradable images.  
 
 
 
 
 DR: Quadratic Kappa 
Region 
Regional 
Grader Algorithm 
All 
0.776 
[0.757-0.792] 
0.846 
[0.835-0.856] 
1 
0.862 
[0.813-0.904] 
0.856 
[0.811-0.891] 
2 
0.806 
[0.724-0.879] 
0.852 
[0.808-0.886] 
3 
0.633 
[0.507-0.746] 
0.745 
[0.690-0.793] 
4 
0.658 
[0.544-0.760] 
0.820 
[0.755-0.873] 
5 
0.836 
[0.778-0.886] 
0.853 
[0.795-0.905] 
6 
0.689 
[0.605-0.760] 
0.785 
[0.737-0.828] 
7 
0.664 
[0.604-0.720] 
0.850 
[0.822-0.876] 
8 
0.878 
[0.851-0.900] 
0.862 
[0.835-0.884] 
9 
0.643 
[0.567-0.715] 
0.823 
[0.786-0.850] 
10 
0.816 
[0.769-0.857] 
0.872 
[0.840-0.899] 
11 
0.735 
[0.640-0.814] 
0.864 
[0.800-0.915] 
12 
0.815 
[0.742-0.878] 
0.866 
[0.829-0.897] 
13 
0.823 
[0.761-0.870] 
0.830 
[0.791-0.861] 
 
T​​able S5. ​​Performance of the grader compared to the algorithm by region for DR. Agreement is measured in terms of 
quadratic weighted kappa and unweighted kappa for the 4 categories of DR (No/Mild, Moderate, Severe, Proliferative) 
 
 
  
 
 
 
Camera Make Camera Models 
3nethra Classic 
Canon CR-2 
Kowa VX-10, VX-20, Nonmyd 7, Nonmyd WD, Nonmyd ​a-D III 8300 
Nidek AFC-210, AFC-230, AFC-300 
Topcon TRC NW-8 
Zeiss Visucam 200 
 
Table S6.​​ Camera make and models used in the study. 31 total cameras (1-6 per region) were used to acquire the fundus 
images. 
 
 
A. Severe or worse DR 
 
 
B. PDR 
 
 
  
 
C. Moderate or worse DR and/or DME 
 
 
 
D. PDR and/or DME 
 
 
 
 
Figure S1.​​ ​Comparison of the performance of the algorithm with regional graders for varying severities and combination 
of DR and DME for all gradable images. The rest of the combinations are in Figure 2 of the main manuscript. 
 
 
   
   
Figure S2. ​​Comparison of sensitivity and specificity of regional graders and the algorithm based on the maximum 
confidence score of the algorithm. The algorithm is more sensitive than regional graders at all levels of confidence but 
less specific for low-confidence images (where the algorithm confidence scores <0.7). 
 
